Update on statin-mediated anti-inflammatory activities in atherosclerosis (Q37470209)

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Safety of statins: focus on clinical pharmacokinetics and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Statins induce regulatory T cell recruitment via a CCL1 dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Lovastatin-induced apoptosis in macrophages through the Rac1/Cdc42/JNK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Reduction of myocardial infarct size by fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Atorvastatin induces tissue transglutaminase in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Atorvastatin induces T cell anergy via phosphorylation of ERK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-009-0150-Y

Regulation of the mevalonate pathway

21 January 2018

1 reference

12 December 2020

Cardioprotective effects of pitavastatin on cardiac performance and remodeling in failing rat hearts

1 reference

12 December 2020

Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects

1 reference

12 December 2020

Statins and blood pressure regulation.

1 reference

12 December 2020

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

12 December 2020

Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B

1 reference

12 December 2020

Pharmacological approaches to improve endothelial repair mechanisms

1 reference

12 December 2020

Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells

1 reference

12 December 2020

The immune response in atherosclerosis: a double-edged sword

1 reference

12 December 2020

Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions

1 reference

12 December 2020

Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice

1 reference

12 December 2020

Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow

1 reference

12 December 2020

Simvastatin treatment in subjects at high cardiovascular risk modulates AT1R expression on circulating monocytes and T lymphocytes.

1 reference

12 December 2020

Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titrati

1 reference

12 December 2020

Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes

1 reference

12 December 2020

Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study

1 reference

12 December 2020

Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.

1 reference

12 December 2020

The effects of atorvastatin in experimental autoimmune uveitis

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia

1 reference

12 December 2020

Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation

1 reference

12 December 2020

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers

1 reference

12 December 2020

HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes

1 reference

12 December 2020

Cellular uptake of fluvastatin, an inhibitor of HMG-CoA reductase, by rat cultured hepatocytes and human aortic endothelial cells

1 reference

12 December 2020

Inflammation, thrombosis and acute coronary syndromes

1 reference

12 December 2020

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

12 December 2020

Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway

1 reference

12 December 2020

Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome

1 reference

12 December 2020

Effect of pravastatin, simvastatin and atorvastatin on the phagocytic activity of mouse peritoneal macrophages

1 reference

12 December 2020

Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.

1 reference

12 December 2020

The influence of treatment of hypercholesterolemic patients with simvastatin on plasma chemotactic activity and adherence of neutrophils

1 reference

12 December 2020

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

12 December 2020

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis

1 reference

12 December 2020

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Prevention of chronic rejection by pravastatin in a rat kidney transplant model

1 reference

12 December 2020

Statins activate AMP-activated protein kinase in vitro and in vivo

1 reference

12 December 2020

Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury

1 reference

12 December 2020

Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond

1 reference

12 December 2020

Prevalence of conventional risk factors in patients with coronary heart disease

1 reference

12 December 2020

Traditional risk factors for coronary heart disease

1 reference

12 December 2020

Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection.

1 reference

12 December 2020

Statins disrupt CCR5 and RANTES expression levels in CD4(+) T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1

1 reference

12 December 2020

Clinical efficacy and safety of statins in managing cardiovascular risk

1 reference

12 December 2020

Rosuvastatin reduces atherosclerotic lesions and promotes progenitor cell mobilisation and recruitment in apolipoprotein E knockout mice.

1 reference

12 December 2020

Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench

1 reference

12 December 2020

Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus

1 reference

12 December 2020

Fluvastatin induces apoptosis of vascular endothelial cells: blockade by glucocorticoids

1 reference

12 December 2020

The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation

1 reference

12 December 2020

Effects of pitavastatin on adiponectin in patients with hyperlipidemia

1 reference

12 December 2020

Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells

1 reference

12 December 2020

Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2.

1 reference

12 December 2020

Pravastatin prolongs graft survival in an allogeneic rat model of orthotopic single lung transplantation.

1 reference

12 December 2020

Effects of pravastatin on the function of dendritic cells in patients with coronary heart disease

1 reference

12 December 2020

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

1 reference

12 December 2020

Fluvastatin increases the expression of adhesion molecules, monocyte chemoattractant protein-1 and tissue factor in HUVEC stimulated by patient IgG fractions containing antiphospholipid antibodies

1 reference

12 December 2020

High dosage of simvastatin reduces TNF-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1beta in vitro

1 reference

12 December 2020

Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.

1 reference

12 December 2020

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

1 reference

12 December 2020

A gift from nature: the birth of the statins

1 reference

12 December 2020

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial

1 reference

12 December 2020

Risks associated with statin therapy: a systematic overview of randomized clinical trials

1 reference

12 December 2020

Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes

1 reference

12 December 2020

The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it--almost

1 reference

12 December 2020

Inflammation and atherosclerosis: role of C-reactive protein in risk assessment

1 reference

12 December 2020

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

1 reference

12 December 2020

Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events

1 reference

12 December 2020

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).

1 reference

12 December 2020

Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis

1 reference

12 December 2020

Intravenous rosuvastatin for acute stroke treatment: an animal study

1 reference

12 December 2020

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

12 December 2020

Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo

1 reference

12 December 2020

Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway

1 reference

12 December 2020

Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure

1 reference

12 December 2020

Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Toward immunomodulatory and anti-inflammatory properties of statins

1 reference

12 December 2020

Statins inhibit hypoxia-induced endothelial proliferation by preventing calcium-induced ROS formation

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Physiological role of ROCKs in the cardiovascular system

1 reference

12 December 2020

The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia

1 reference

12 December 2020

Fluvastatin increases prostacyclin and decreases endothelin production by human umbilical vein endothelial cells

1 reference

12 December 2020

Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST

1 reference

12 December 2020

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

1 reference

12 December 2020

AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase

1 reference

12 December 2020

The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat.

1 reference

12 December 2020

Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives

1 reference

12 December 2020

Rosuvastatin in older patients with systolic heart failure

1 reference

12 December 2020

Pravastatin prevents myocardium from ischemia-induced fibrosis by protecting vascular endothelial cells exposed to oxidative stress

1 reference

12 December 2020

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

1 reference

12 December 2020

Recent evidence for an involvement of rho-kinase in cerebral vascular disease

1 reference

12 December 2020

Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats

1 reference

12 December 2020

Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes.

1 reference

12 December 2020

Effects of statins on adhesion molecule expression in endothelial cells

1 reference

12 December 2020

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Atorvastatin attenuates cardiomyocyte loss in adult rats from protein-restricted dams.

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

Mevalonate pathway: a review of clinical and therapeutical implications

1 reference

12 December 2020

Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice.

1 reference

12 December 2020

Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway

1 reference

12 December 2020

Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B)-nuclear factor-kappa B pathway by lovastatin limits endothelial-monocyte cell interaction

1 reference

12 December 2020

Who should receive a statin these days? Lessons from recent clinical trials

1 reference

12 December 2020

Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury

1 reference

12 December 2020

Aortic eNOS expression and phosphorylation in Apo-E knockout mice: differing effects of rapamycin and simvastatin.

1 reference

12 December 2020

Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome

1 reference

12 December 2020

Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes

1 reference

12 December 2020

Simvastatin: two decades in a circle

1 reference

12 December 2020

Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice

1 reference

12 December 2020

Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line

1 reference

12 December 2020

Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration

1 reference

12 December 2020

Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein

1 reference

12 December 2020

High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins

1 reference

12 December 2020

Statins as a newly recognized type of immunomodulator

1 reference

12 December 2020

Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins

1 reference

12 December 2020

Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy

1 reference

12 December 2020

Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.

1 reference

12 December 2020

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Effects of Atorvastatin on Inflammatory and Fibrinolytic Parameters in Patients with Chronic Kidney Disease

1 reference

12 December 2020

Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation.

1 reference

12 December 2020

Lovastatin reduces apoptosis and downregulates the CD40 expression induced by TNF-alpha in cerebral vascular endothelial cells

1 reference

12 December 2020

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

12 December 2020

Rho effectors and reorganization of actin cytoskeleton

1 reference

12 December 2020

Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells

1 reference

12 December 2020

Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.

1 reference

12 December 2020

HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Effect of simvastatin therapy on cell membrane cholesterol content and membrane function as assessed by polymorphonuclear cell NADPH oxidase activity

1 reference

12 December 2020

Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells

1 reference

12 December 2020

3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells

1 reference

12 December 2020

Update on statins: 2003.

1 reference

12 December 2020

Pravastatin attenuates ceramide-induced cytotoxicity in mouse cerebral endothelial cells with HIF-1 activation and VEGF upregulation

1 reference

12 December 2020

Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angiopl

1 reference

12 December 2020

Major risk factors as antecedents of fatal and nonfatal coronary heart disease events

1 reference

12 December 2020

Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells

1 reference

12 December 2020

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization

1 reference

12 December 2020

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

12 December 2020

Update for primary healthcare providers: recent statin trials and revised National Cholesterol Education Program III guidelines.

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle.

1 reference

12 December 2020

The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk

1 reference

12 December 2020

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells

1 reference

12 December 2020

Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes.

1 reference

12 December 2020

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

12 December 2020

Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ

1 reference

12 December 2020

Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions

1 reference

12 December 2020

Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases.

1 reference

12 December 2020

Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase

1 reference

12 December 2020

Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function

1 reference

12 December 2020

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)

1 reference

12 December 2020

HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo

1 reference

12 December 2020

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

1 reference

12 December 2020

AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function

1 reference

12 December 2020

AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells

1 reference

12 December 2020

Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies

1 reference

12 December 2020

Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction

1 reference

12 December 2020

Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study

1 reference

12 December 2020

Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease.

1 reference

12 December 2020

Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses.

1 reference

12 December 2020

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

1 reference

12 December 2020

Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy

1 reference

12 December 2020

Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects

1 reference

12 December 2020

Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injury

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

12 December 2020

Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages

1 reference

12 December 2020

Intensive statin therapy after stroke or transient ischemic attack: a SPARCLing success?

1 reference

12 December 2020

Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study

1 reference

12 December 2020

Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products

1 reference

12 December 2020

Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats

1 reference

12 December 2020

Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis

1 reference

12 December 2020

Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.

1 reference

12 December 2020

Effect of atorvastatin on TH1 and TH2 cytokine secreting cells during T cell activation and differentiation

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

12 December 2020

Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production

1 reference

12 December 2020

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

12 December 2020

Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosis

1 reference

12 December 2020

Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury

1 reference

12 December 2020

Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin

1 reference

12 December 2020

Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia

1 reference

12 December 2020

Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials

1 reference

12 December 2020

Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial

1 reference

12 December 2020

Lovastatin modulation of microglial activation via suppression of functional CD40 expression

1 reference

12 December 2020

HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage

1 reference

12 December 2020

Pravastatin promotes coronary collateral circulation in patients with coronary artery disease

1 reference

12 December 2020

Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase

1 reference

12 December 2020

Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma

1 reference

12 December 2020

Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation

1 reference

12 December 2020

Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury

1 reference

12 December 2020

Dual mode of HMG-CoA reductase inhibition on dendritic cell invasion

1 reference

12 December 2020

Possible involvement of Akt activity in endothelial dysfunction in type 2 diabetic mice

1 reference

12 December 2020

Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors

1 reference

12 December 2020

Statin myopathy: an update

1 reference

12 December 2020

Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020